Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.
Reads0
Chats0
TLDR
Current knowledge on the relations between the polymorphisms of some CYPs and drug activity/toxicity and cancer risk is reviewed.Abstract:
The polymorphic P450 (CYP) enzyme superfamily is the most important system involved in the biotransformation of many endogenous and exogenous substances including drugs, toxins, and carcinogens. Genotyping for CYP polymorphisms provides important genetic information that help to understand the effects of xenobiotics on human body. For drug metabolism, the most important polymorphisms are those of the genes coding for CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5, which can result in therapeutic failure or severe adverse reactions. Genes coding for CYP1A1, CYP1A2, CYP1B1, and CYP2E1 are among the most responsible for the biotransformation of chemicals, especially for the metabolic activation of pre-carcinogens. There is evidence of association between gene polymorphism and cancer susceptibility. Pathways of carcinogen metabolism are complex, and are mediated by activities of multiple genes, while single genes have a limited impact on cancer risk. Multigenic approach in addition to environmental determinants in large sample studies is crucial for a reliable evaluation of any moderate gene effect. This article brings a review of current knowledge on the relations between the polymorphisms of some CYPs and drug activity/toxicity and cancer risk.read more
Citations
More filters
Journal ArticleDOI
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.
Bei Wang,Lujin Wu,Jing Chen,Lingli Dong,Chen Chen,Zheng Wen,Jiong Hu,Ingrid Fleming,Dao Wen Wang +8 more
TL;DR: The arachidonic acid (AA) pathway plays a key role in cardiovascular biology, carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. as mentioned in this paper summarizes the physiological and pathophysiological importance of the AA metabolizing pathways and outlines the molecular mechanisms underlying the actions of AA related to its three main metabolic pathways in CVD and cancer progression.
Journal ArticleDOI
Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
Michael E. Grossmann,Amitabha Ray,Katai J. Nkhata,Dmitry A. Malakhov,Olga P. Rogozina,Soner Dogan,Margot P. Cleary +6 more
TL;DR: Speculators believe that higher circulating levels of leptin found in obese subjects could be a growth-enhancing factor as supported by in vitro and preclinical studies, whereas low adiponectin levels in obese women may be permissive for leptin’s growth-promoting effects.
Journal ArticleDOI
Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm
Bo Zhang,Yan Zhou,Yan Zhou,Nan Lin,Rebecca F. Lowdon,Chibo Hong,Raman P. Nagarajan,Jeffrey B. Cheng,Daofeng Li,Michael Stevens,Hyung Joo Lee,Xiaoyun Xing,Jia Zhou,Vasavi Sundaram,Ginell Elliott,Junchen Gu,Taoping Shi,Philippe Gascard,Mahvash Sigaroudinia,Thea D. Tlsty,Theresa A. Kadlecek,Arthur Weiss,Henriette O'Geen,Peggy J. Farnham,Cecile L. Maire,Keith L. Ligon,Keith L. Ligon,Pamela A. F. Madden,Angela Tam,Richard A. Moore,Martin Hirst,Martin Hirst,Marco A. Marra,Baoxue Zhang,Joseph F. Costello,Ting Wang +35 more
TL;DR: Comprehensive analysis of nineteen human DNA methylomes with M&M reveals distinct DNA methylation patterns among different tissue types, cell types, and individuals, potentially underscoring divergent epigenetic regulation at different scales of phenotypic diversity.
Journal ArticleDOI
Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application
TL;DR: Clinical applications to alter detoxification pathway activity and improve patient outcomes are considered, drawing on the growing understanding of the relationship between detoxification functions and different disease states, genetic polymorphisms, and drug-nutrient interactions.
Journal ArticleDOI
Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation
TL;DR: This review discusses the recent progress towards the use of P450 enzymes in a variety of applications, and expands upon the current progress in P450 engineering approaches describing several recent examples that are utilized to enhance heterologous expression, stability, catalytic efficiency and utilization of alternate oxidants.
References
More filters
Journal ArticleDOI
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
TL;DR: The incidence of serious and fatal adverse drug reactions in US hospitals was found to be extremely high, and data suggest that ADRs represent an important clinical issue.
Journal ArticleDOI
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
Peter M. Kuehl,Jiong Zhang,Yvonne S. Lin,Jatinder K. Lamba,Mahfoud Assem,John D. Schuetz,Paul B. Watkins,Ann K. Daly,Steven A. Wrighton,Stephen D. Hall,Patrick Maurel,Mary V. Relling,Cynthia Brimer,Kazuto Yasuda,Raman Venkataramanan,Stephen C. Strom,Kenneth E. Thummel,Mark S. Boguski,Erin G. Schuetz +18 more
TL;DR: CYP3A5 was more frequently expressed in livers of African Americans than in those of Caucasians, and may be the most important genetic contributor to interindividual and interracial differences in CYP3A-dependent drug clearance and in responses to many medicines.
Journal ArticleDOI
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
TL;DR: Several issues remain to be resolved regarding the catalytic activity of the P-450 3A4 protein, including rate-limiting steps and the need for cytochrome b5, divalent cations, and acidic phospholipid systems for optimal activity.
Journal ArticleDOI
Induction of phase I, II and III drug metabolism/transport by xenobiotics
TL;DR: Drug metabolizing enzymes (DMEs) play central roles in the metabolism, elimination and detoxification of xenobiotics and drugs introduced into the human body, and play crucial roles in response to many polycyclic aromatic hydrocarbon receptors and excretion.
Journal ArticleDOI
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
TL;DR: Predictive CYP2D6 genotyping is estimated by the author to be beneficial for treatment of about 30–40% of CYP 2D6 drug substrates, that is, for about 7–10% of all drugs clinically used, although prospective clinical studies are necessary to evaluate the exact benefit of drug selection and dosage.
Related Papers (5)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Cytochrome P450 pharmacogenetics and cancer.
Polymorphism of human cytochrome P450 enzymes and its clinical impact
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis.
Metabolic gene polymorphism frequencies in control populations.
Seymour Garte,Laura Gaspari,A.-K. Alexandrie,Christine B. Ambrosone,Herman Autrup,Judith L. Autrup,H. Baranova,L. Bathum,Simone Benhamou,Paolo Boffetta,C. Bouchardy,K. Breskvar,J. Brockmöller,Ingolf Cascorbi,Margie L. Clapper,Christiane Coutelle,Ann K. Daly,Marco Dell'Omo,Vita Dolzan,C.M. Dresler,Anthony A. Fryer,Aage Haugen,David W. Hein,Allan Hildesheim,Ari Hirvonen,L.L. Hsieh,Magnus Ingelman-Sundberg,Ivan Kalina,Daehee Kang,Masahiro Kihara,Chikako Kiyohara,Pierre Kremers,Philip Lazarus,Loic Le Marchand,Maria Celeste Lechner,E.M.M. van Lieshout,Stephanie J. London,Johannes J. Manni,Christine Maugard,S. Morita,Valle Nazar-Stewart,K. Noda,Yoshio Oda,Fritz F. Parl,Roberta Pastorelli,I. Persson,Wilbert H.M. Peters,Agneta Rannug,Timothy R. Rebbeck,Angela Risch,L. Roelandt,Marjorie Romkes,David Ryberg,Salagovic J,Bernadette Schoket,Janeric Seidegård,Peter G. Shields,Edith Sim,D. Sinnet,Richard C. Strange,Isabelle Stücker,Haruhiko Sugimura,Jordi To-Figueras,Paolo Vineis,M.C. Yu,Emanuela Taioli +65 more